GlassScriptPhysician profile
Michael Jacob Antony
NPI 1780209361
$855.63
in general payments reported to CMS, 2019-2025
7 companies · $421 in 2025
The $421 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.34 · 2024: $393 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $281.49 | 2023-2025 | Conmed Dilation, Conmed Hemostasis, Conmed Generators |
| Olympus America INC. | $180.66 | 2025 | Gastrointestinal Videoscope, Evis Exera III Colonovideoscope, Single Use Biliary Balloon Dilator |
| Boston Scientific Corporation | $162.70 | 2024-2025 | Resolution 360 Clip, General - Hemostasis, Exalt Model D |
| Micro-Tech Endoscopy USA, INC. | $135.73 | 2025 | Eyemax |
| Abbvie INC. | $61.24 | 2024 | |
| Genzyme Corporation | $20.89 | 2024 | |
| Celgene Corporation | $12.92 | 2023 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Antony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.